Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹801.88 Cr
Profit after tax
₹71.75 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations801.88−1.03%3,473.96
Other income13.78+4.81%49.80
Total income815.66−0.94%3,523.76
Employee benefit expense113.18+6.89%423.13
Finance costs9.61−29.69%61.44
Depreciation & amortisation39.06−1.13%164.47
Total expenses719.10−0.09%2,975.79
Profit before tax96.56+5.60%535.81
Tax expense24.82+13.00%135.15
Profit after tax71.75+3.25%400.67
Total comprehensive income95.65+39.32%365.03
Earnings per share
Earnings per share, basic₹2.90₹16.48
Earnings per share, diluted₹2.84₹16.47

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Granules India reported Q1 FY27 revenue of about Rs 1,477 crore, up 22% year-on-year, with EBITDA growing 37% to Rs 339 crore and profit after tax up 60% to Rs 180 crore. Management said complex generics now form about 50% of finished dosages compared to 39% a year earlier, and the peptide CDMO business grew more than 100% year-on-year. The company also stated that remediation work at its Gagillapur facility is essentially complete, with the FDA having raised no concerns on the pace or adequacy of corrective actions to date.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 37 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 13 Aug 2026.